14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state
Abstract Leucine-rich repeat kinase 2 (LRRK2) is an essential regulator in cellular signaling and a major contributor to Parkinson’s disease (PD) pathogenesis. 14-3-3 proteins are critical modulators of LRRK2 activity, yet the structural basis of their interaction has remained unclear. Here, we pres...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-62337-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849234946550398976 |
|---|---|
| author | Juliana A. Martinez Fiesco Alexandra Beilina Astrid Alvarez de la Cruz Ning Li Riley D. Metcalfe Mark R. Cookson Ping Zhang |
| author_facet | Juliana A. Martinez Fiesco Alexandra Beilina Astrid Alvarez de la Cruz Ning Li Riley D. Metcalfe Mark R. Cookson Ping Zhang |
| author_sort | Juliana A. Martinez Fiesco |
| collection | DOAJ |
| description | Abstract Leucine-rich repeat kinase 2 (LRRK2) is an essential regulator in cellular signaling and a major contributor to Parkinson’s disease (PD) pathogenesis. 14-3-3 proteins are critical modulators of LRRK2 activity, yet the structural basis of their interaction has remained unclear. Here, we present the cryo-electron microscopy structure of the LRRK2:14-3-32 autoinhibitory complex, revealing how a 14-3-3 dimer stabilizes an autoinhibited LRRK2 monomer through dual-site anchoring. The dimer engages both phosphorylated S910/S935 sites and the COR-A/B subdomains within the Roc-COR GTPase region. This spatial configuration constrains LRR domain mobility, reinforces the inactive conformation, and likely impedes LRRK2 dimerization and oligomer formation. Structure-guided mutagenesis studies show that PD-associated mutations at the COR:14-3-32 interface and within the GTPase domain weaken 14-3-3 binding and impair its inhibitory effect on LRRK2 kinase activity. Furthermore, we demonstrate that type I LRRK2 kinase inhibitor, which stabilizes the kinase domain in its active conformation, reduces 14-3-3 binding and promotes dephosphorylation at pS910 and pS935. Together, these findings provide a structural basis for understanding how LRRK2 is maintained in an inactive state, elucidate the mechanistic role of 14-3-3 in LRRK2 regulation, inform the interpretation of PD biomarkers, and suggest therapeutic strategies aimed at enhancing LRRK2-14-3-3 interactions to treat PD and related disorders. |
| format | Article |
| id | doaj-art-d050d41bbe9a4705adb48ff615ce6467 |
| institution | Kabale University |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-d050d41bbe9a4705adb48ff615ce64672025-08-20T04:02:56ZengNature PortfolioNature Communications2041-17232025-08-0116111710.1038/s41467-025-62337-114-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive stateJuliana A. Martinez Fiesco0Alexandra Beilina1Astrid Alvarez de la Cruz2Ning Li3Riley D. Metcalfe4Mark R. Cookson5Ping Zhang6Kinase Complexes Section, Center for Structural Biology, Center for Cancer Research, National Cancer InstituteCell Biology and Gene Expression Section, National Institute on Aging, National Institutes of HealthKinase Complexes Section, Center for Structural Biology, Center for Cancer Research, National Cancer InstituteKinase Complexes Section, Center for Structural Biology, Center for Cancer Research, National Cancer InstituteKinase Complexes Section, Center for Structural Biology, Center for Cancer Research, National Cancer InstituteCell Biology and Gene Expression Section, National Institute on Aging, National Institutes of HealthKinase Complexes Section, Center for Structural Biology, Center for Cancer Research, National Cancer InstituteAbstract Leucine-rich repeat kinase 2 (LRRK2) is an essential regulator in cellular signaling and a major contributor to Parkinson’s disease (PD) pathogenesis. 14-3-3 proteins are critical modulators of LRRK2 activity, yet the structural basis of their interaction has remained unclear. Here, we present the cryo-electron microscopy structure of the LRRK2:14-3-32 autoinhibitory complex, revealing how a 14-3-3 dimer stabilizes an autoinhibited LRRK2 monomer through dual-site anchoring. The dimer engages both phosphorylated S910/S935 sites and the COR-A/B subdomains within the Roc-COR GTPase region. This spatial configuration constrains LRR domain mobility, reinforces the inactive conformation, and likely impedes LRRK2 dimerization and oligomer formation. Structure-guided mutagenesis studies show that PD-associated mutations at the COR:14-3-32 interface and within the GTPase domain weaken 14-3-3 binding and impair its inhibitory effect on LRRK2 kinase activity. Furthermore, we demonstrate that type I LRRK2 kinase inhibitor, which stabilizes the kinase domain in its active conformation, reduces 14-3-3 binding and promotes dephosphorylation at pS910 and pS935. Together, these findings provide a structural basis for understanding how LRRK2 is maintained in an inactive state, elucidate the mechanistic role of 14-3-3 in LRRK2 regulation, inform the interpretation of PD biomarkers, and suggest therapeutic strategies aimed at enhancing LRRK2-14-3-3 interactions to treat PD and related disorders.https://doi.org/10.1038/s41467-025-62337-1 |
| spellingShingle | Juliana A. Martinez Fiesco Alexandra Beilina Astrid Alvarez de la Cruz Ning Li Riley D. Metcalfe Mark R. Cookson Ping Zhang 14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state Nature Communications |
| title | 14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state |
| title_full | 14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state |
| title_fullStr | 14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state |
| title_full_unstemmed | 14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state |
| title_short | 14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state |
| title_sort | 14 3 3 binding maintains the parkinson s associated kinase lrrk2 in an inactive state |
| url | https://doi.org/10.1038/s41467-025-62337-1 |
| work_keys_str_mv | AT julianaamartinezfiesco 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate AT alexandrabeilina 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate AT astridalvarezdelacruz 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate AT ningli 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate AT rileydmetcalfe 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate AT markrcookson 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate AT pingzhang 1433bindingmaintainstheparkinsonsassociatedkinaselrrk2inaninactivestate |